Skip to main content

Table 1 Baseline characteristics and blood pressure (BP) of 4,412 patients with hypertension with and without VKA Treatment

From: General Practitioners’ vitamin K antagonist monitoring is associated with better blood pressure control in patients with hypertension – a cross-sectional database study

  VKA group n = 569 Control group n = 3,843 p-value**
Age, years (SD) 76.7 (10.0) 67.8 (13.8) <0.01
Men, % 47.6 52.4 0.044
Consultations/year, n (SD) 10.9 (7.2) 6.6 (5.5) <0.01
Chronic conditions, n (SD) 3.8 (2.5) 3.1 (2.3) <0.01
   Coronary heart disease, n (%) 45 (7.9) 224 (5.8) 0.053
   Heart failure, n (%) 28 (4.9) 50 (1.3) <0.01
   Atherosclerosis, n (%) 28 (4.9) 80 (2.1) <0.01
   Obesity, n (%) 20 (3.5) 235 (6.1) 0.01
   Diabetes, n (%) 87 (15.3) 557 (14.5) 0.62
Mean systolic BP, mm Hg (SD) 130.6 (14.9) 139.8 (15.8) <0.01
Mean diastolic BP, mm Hg (SD) 76.6 (7.9) 81.3 (9.3) <0.01
Patients with controlled* BP, % 74.9 49.4 <0.01
  1. *defined as blood pressure <140/90 mmHg
  2. **p-value: Results of univariate comparisons between groups based on unpaired t-test or Chi-square test as appropriate